Intuitive Surgical (NASDAQ:ISRG) Research Coverage Started at HSBC

HSBC assumed coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a research note issued to investors on Friday morning, Marketbeat reports. The brokerage issued a buy rating and a $318.00 target price on the medical equipment provider’s stock.

A number of other equities analysts have also commented on the stock. Wells Fargo & Company reduced their price target on shares of Intuitive Surgical from $386.00 to $363.00 and set an overweight rating on the stock in a research report on Friday, October 20th. Raymond James dropped their price target on Intuitive Surgical from $368.00 to $310.00 and set an outperform rating for the company in a report on Friday, October 20th. Royal Bank of Canada reissued an outperform rating and issued a $355.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 20th. UBS Group lowered their target price on Intuitive Surgical from $385.00 to $314.00 and set a neutral rating for the company in a research note on Thursday, October 19th. Finally, Barclays upped their price target on shares of Intuitive Surgical from $314.00 to $385.00 and gave the stock an overweight rating in a research report on Monday, July 24th. Five investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of $342.71.

Intuitive Surgical Trading Up 2.0 %

Shares of NASDAQ:ISRG opened at $311.34 on Friday. Intuitive Surgical has a 1-year low of $222.65 and a 1-year high of $358.07. The firm has a market capitalization of $109.61 billion, a PE ratio of 73.26, a PEG ratio of 4.85 and a beta of 1.31. The business’s 50 day moving average is $284.44 and its 200-day moving average is $305.17.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.06. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 22.14%. Intuitive Surgical’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.90 EPS. On average, sell-side analysts predict that Intuitive Surgical will post 4.54 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now directly owns 702 shares of the company’s stock, valued at approximately $214,587.36. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now directly owns 702 shares of the company’s stock, valued at approximately $214,587.36. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $290.00, for a total value of $580,000.00. Following the completion of the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $7,342,510. The disclosure for this sale can be found here. In the last ninety days, insiders sold 55,208 shares of company stock worth $15,275,529. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Large investors have recently bought and sold shares of the business. HHM Wealth Advisors LLC increased its stake in Intuitive Surgical by 1,314.3% during the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 92 shares in the last quarter. Solstein Capital LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $25,000. OFI Invest Asset Management bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $25,000. RFP Financial Group LLC increased its stake in Intuitive Surgical by 166.7% during the 2nd quarter. RFP Financial Group LLC now owns 80 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 50 shares in the last quarter. Finally, Marquette Asset Management LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth approximately $28,000. 82.91% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.